Return to search results
Doxepin hydrochloride
Doxepin Hydrochloride is a generic prescription medication, available as oral capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg. Manufactured by Leading Pharma, LLC, it belongs to the tricyclic antidepressant class and is used to treat conditions like depression and anxiety. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Doxepin Hydrochloride is a generic prescription medication, available as oral capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg. Manufactured by Leading Pharma, LLC, it belongs to the tricyclic antidepressant class and is used to treat conditions like depression and anxiety. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Doxepin hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Doxepin hydrochloride — ANDA 207482 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207482"
}
]
|
| identifier | ANDA207482 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"health-care",
"medications",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Doxepin hydrochloride |
